Related Experiment Video
Updated: Aug 29, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
The mouse homolog of PKD1: sequence analysis and alternative splicing
C Löhning1, U Nowicka, A M Frischauf
1Imperial Cancer Research Fund, Molecular Analysis of Mammalian Mutation, Lincoln's Inn Fields, London WC2A 3PX, UK.
Abstract:
We have cloned and sequenced the mouse transcript homologous to human polycystic kidney disease 1 (PKD1). The predicted protein is 79% identical to human PKD1 and shows the presence of most of the domains identified in the human sequence. Since the mouse homolog is transcribed from a unique gene and there are no transcribed, closely related copies as has been observed for human PKD1, we have been able to investigate alternative splicing of the transcript. At the junction of exons 12 and 13, several different splicing variants lead to a predicted protein that would be secreted. These forms are predominantly found in newborn brain, while in kidney the transcript homologous to the previously described human RNA predominates.
Related Concept Videos
In-vitro Mutagenesis (Gene Knockouts)
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

